Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lia Molinari

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
JCO Clinical Cancer Informatics|October 22, 2019
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical OutcomesGian Maria Zaccaria, Simone Ferrero, Samanta Rosati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2004
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphomaPier Luigi Zinzani, Alessandro Pulsoni, Alessio Perrotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trialMaurizio Martelli, Filippo Gherlinzoni, Amalia De Renzo, et al.
Bone Marrow Transplantation|June 17, 2020
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana LinfomiMichele Merli, Stefano Luminari, Lucia Farina, et al.
The Lancet. Oncology|May 17, 2014
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trialUmberto Vitolo, Annalisa Chiappella, Silvia Franceschetti, et al.
Hematological Oncology|March 19, 2021
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working GroupGian Matteo Rigolin, Francesco Cavazzini, Alfonso Piciocchi, et al.
Leukemia & Lymphoma|October 9, 2021
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana LinfomiAnnalisa Arcari, Lucia Morello, Daniele Vallisa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2021
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell LymphomaGrzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
JCO Clinical Cancer Informatics|October 22, 2019
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical OutcomesGian Maria Zaccaria, Simone Ferrero, Samanta Rosati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2004
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphomaPier Luigi Zinzani, Alessandro Pulsoni, Alessio Perrotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trialMaurizio Martelli, Filippo Gherlinzoni, Amalia De Renzo, et al.
Bone Marrow Transplantation|June 17, 2020
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana LinfomiMichele Merli, Stefano Luminari, Lucia Farina, et al.
The Lancet. Oncology|May 17, 2014
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trialUmberto Vitolo, Annalisa Chiappella, Silvia Franceschetti, et al.
Hematological Oncology|March 19, 2021
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working GroupGian Matteo Rigolin, Francesco Cavazzini, Alfonso Piciocchi, et al.
Leukemia & Lymphoma|October 9, 2021
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana LinfomiAnnalisa Arcari, Lucia Morello, Daniele Vallisa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2021
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell LymphomaGrzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, et al.
Pageof 2